NuvOx Pharma Competitors and Similar CompaniesClear all

NuvOx Pharma's competitors and similar companies include Genentech, Cipla, Mankind Pharma and Alembic Pharmaceuticals.

	NuvOx Pharma NuvOx Pharma is a biotechnology company specializing in oxygen therapeutics.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	Mankind Pharma Mankind Pharma is a pharmaceutical company developing, commercializing, and delivering medicines.	Alembic Pharmaceuticals Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates
Founding Date	Founding Date 2008	Founding Date 1976	Founding Date 1935	Founding Date 1995	Founding Date 2010
Type	Type Private	Type Subsidiary	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Tucson, US HQ	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations New Delhi, IN HQ	Locations Vadodara, IN HQ Baska, IN Mumbai, IN Namthang, IN Vadodara, IN Vadodara, IN
Employees	Employees 129% increase	Employees 18,077	Employees 27,764	Employees 16,2532% increase	Employees 14,858
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) N/A	Revenue (est.) ₹73.4b (FY, 2026)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹97.2b (FY, 2026)	Cost of goods N/A	Cost of goods ₹19.8b (FY, 2026)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ₹184.4b (FY, 2026)	Gross profit N/A	Gross profit ₹54.1b (FY, 2026)
Net income	Net income N/A	Net income N/A	Net income ₹38.7b (FY, 2026)	Net income N/A	Net income ₹6.7b (FY, 2026)
Operating ⚠
Products	Products N/A	Products N/A	Products 1.5 k (FY, 2024)	Products N/A	Products 145 (FY, 2024)
Funding
Latest funding round	Latest funding round $ 2m (almost 8 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 215m (about 11 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 17.1m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 239m	Total funding raised N/A